The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
The role of liposomes in clinical nanomedicine development. What now? Now what?
Open accessAbstract
The rapid rise in interest in 'nanomedicines' in the academic world over the last twenty years and the claims of success led to calls for reflection. The main body of text of this Commentary will be on answering the question: 'where to go with nanomedicines'? Research priorities for the future will be outlined based on experience with the most successful nanomedicines family within the broad field of nanomedicine so far: liposomes. An analysis of currently clinically tested, approved and marketed liposome-drug combinations provides these insights.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danhier, F. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.11.015 · Cited by 1,288
Lancet, J. E., Uy, G. L., Cortes, J. E., Newell, L. F., Lin, T. L., Ritchie, E. K., Stuart, R. K., Strickland, S. A., Hogge, D., Solomon, S. R., et al. (2018) · Journal of Clinical Oncology · doi:10.1200/jco.2017.77.6112 · Cited by 1,025
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come
Yingchoncharoen, P., Kalinowski, D. S., & Richardson, D. R. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012070 · Cited by 744
Nanopharmaceuticals (part 1): products on the market
Weissig, V., Pettinger, T., & Murdock, N. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s46900 · Cited by 591
Pujade-Lauraine, E., Wagner, U., Aavall-Lundqvist, E., Gebski, V., Heywood, M., Vasey, P. A., Volgger, B., Vergote, I., Pignata, S., Ferrero, A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.7519 · Cited by 575
Adjuvant system AS01: helping to overcome the challenges of modern vaccines
Didierlaurent, A. M., Laupèze, B., Di Pasquale, A., Hergli, N., Collignon, C., & Garçon, N. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2016.1213632 · Cited by 516
Single-Dose Liposomal Amphotericin B for Visceral Leishmaniasis in India
Sundar, S., Chakravarty, J., Agarwal, D., Rai, M., & Murray, H. W. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903627 · Cited by 434
The evolving landscape of drug products containing nanomaterials in the United States
D'Mello, S. R., Cruz, C. N., Chen, M.-L., Kapoor, M., Lee, S. L., & Tyner, K. M. (2017) · Nature Nanotechnology · doi:10.1038/nnano.2017.67 · Cited by 345
Sundar, S., Sinha, P. K., Rai, M., Verma, D. K., Nawin, K., Alam, S., Chakravarty, J., Vaillant, M., Verma, N., Pandey, K., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62050-8 · Cited by 337
Watson, D. S., Endsley, A. N., & Huang, L. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.01.070 · Cited by 322
Liposomes used as a vaccine adjuvant-delivery system: From basics to clinical immunization
Wang, N., Chen, M., & Wang, T. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.04.025 · Cited by 308
Belfiore, L., Saunders, D. N., Ranson, M., Thurecht, K. J., Storm, G., & Vine, K. L. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.02.040 · Cited by 294
Self-citationPetersen, G. H., Alzghari, S. K., Chee, W., Sankari, S. S., & La-Beck, N. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.04.028 · Cited by 290
Ojha, T., Pathak, V., Shi, Y., Hennink, W. E., Moonen, C. T. W., Storm, G., Kiessling, F., & Lammers, T. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.007 · Cited by 260
Self-citationCancer nanomedicine: is targeting our target?
Lammers, T., Kiessling, F., Ashford, M., Hennink, W., Crommelin, D., & Storm, G. (2016) · Nature Reviews Materials · doi:10.1038/natrevmats.2016.69 · Cited by 233
Self-citationLammers, T., Rizzo, L. Y., Storm, G., & Kiessling, F. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1414 · Cited by 195
Self-citationThe beginning of the end of the nanomedicine hype
Park, K. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.044 · Cited by 158
Rifkin, R. M., Gregory, S. A., Mohrbacher, A. M., & Hussein, M. A. (2006) · Cancer · doi:10.1002/cncr.21662 · Cited by 136
Working together: interactions between vaccine antigens and adjuvants
Fox, C. B., Kramer, R. M., Barnes, L., V, Dowling, Q. M., & Vedvick, T. S. (2013) · Therapeutic Advances in Vaccines · doi:10.1177/2051013613480144 · Cited by 117
Comparison between liposomal formulations of amphotericin B
Adler‐Moore, J., Gangneux, J., & Pappas, P. G. (2016) · Medical Mycology · doi:10.1093/mmy/myv111 · Cited by 117
Clinical translation of immunoliposomes for cancer therapy: recent perspectives
Wang, D., Sun, Y., Liu, Y., Meng, F., & Lee, R. J. (2018) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2018.1517747 · Cited by 84
Romero, G. A. S., Costa, D. L., Costa, C. H. N., de Almeida, R. P., de Melo, E. V., de Carvalho, S. F. G., Rabello, A., de Carvalho, A. L., Sousa, A. D. Q., Leite, R. D., et al. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0005706 · Cited by 76
The drug delivery field at the inflection point: Time to fight its way out of the egg
Park, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.07.030 · Cited by 74
Olson, J. A., Adler‐Moore, J., Jensen, G. M., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00870-07 · Cited by 73
Efficacy of liposomal bupivacaine in shoulder surgery: a systematic review and meta-analysis
Kolade, O. O., Patel, K. S., Ihejirika-Lomedico, R. C., et al. (2019) · Journal of Shoulder and Elbow Surgery · doi:10.1016/j.jse.2019.04.054 · Cited by 60
Lee, M.-K. (2018) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-018-0398-0 · Cited by 56
Witzigmann, D., Uhl, P., Sieber, S., Kaufman, C., Einfalt, T., Schöneweis, K., Grossen, P., Buck, J., Ni, Y., Schenk, S., et al. (2019) · eLife · doi:10.7554/elife.42276 · Cited by 34
Update on the role of nanoliposomal irinotecan in the treatment of metastatic pancreatic cancer
Rahman, F. A. U., Ali, S., & Saif, M. W. (2017) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x17705328 · Cited by 30
Liposomes: The Science and the Regulatory Landscape
Crommelin, D. J. A., Metselaar, J. M., & Storm, G. (2015) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-319-16241-6_3 · Cited by 24
Self-citationNCI Centers of Cancer Nanotechnology Excellence (CCNEs) – A full story to set the record straight
Grodzinski, P. A. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.08.016 · Cited by 19
Kunjachan, S., Jose, S., Thomas, C., Joseph, E., Kiessling, F. M., & Lammers, T. (2011) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2011.00955.x · Cited by 18
Leroux, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.03.032 · Cited by 18
Witzigmann, D., Hak, S., & van der Meel, R. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.10.011 · Cited by 15
Liposomal Bupivacaine: A Review and Applications to Dermatologic Surgery
Sorenson, E., & Chesnut, C. (2018) · Dermatologic Surgery · doi:10.1097/dss.0000000000001628 · Cited by 9
Cited by
The blood–brain barrier: Structure, regulation and drug delivery
Wu, D., Chen, Q., Chen, X., Han, F., Chen, Z., & Wang, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01481-w · Cited by 1,906
“engineering and nanotechnology.(250) Various types of functionalization strategies have been involved for the development of liposomal delivery system such as brain/tumor-targeting delivery, controlled drug release, imaging-guided delivery, etc.”
BackgroundLiu, P., Chen, G., & Zhang, J. (2022) · Molecules · doi:10.3390/molecules27041372 · Cited by 1,334
Ghezzi, M., Pescina, S., Padula, C., Santi, P., Del Favero, E., Cantù, L., & Nicoli, S. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.02.031 · Cited by 1,135
Engineering Macrophages for Cancer Immunotherapy and Drug Delivery
Xia, Y., Rao, L., Yao, H., Wang, Z., Ning, P., & Chen, X. (2020) · Advanced Materials · doi:10.1002/adma.202002054 · Cited by 949
Liposomes: Advancements and innovation in the manufacturing process
Shah, S., Dhawan, V., Holm, R., Nagarsenker, M. S., & Perrie, Y. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.002 · Cited by 745
Metadata
- Authors
- Crommelin, D. J. A., van Hoogevest, P., & Storm, G.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2020-02
- Volume
- 318
- Pages
- 256-263
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2995145725
- Cited by
- 349
- References
- 34
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.